This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients. Blake has a unique case because he was a cardiac, cath lab, critical care, and surgery nurse who got into medical sales.
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade.
If a misinterpretation exists between engineers and testers on the solution developed, then such requirements will have higher risks on the entire lifecycle. For example, insights from healthcare providers (HCPs) might be filtered through a medicalscience liaison’s interpretations, leading to gaps in the captured requirements.
Human Xtensions, founded as a result of this idea, thanks to its multi-disciplinary team of engineers, created the unique HandX system. Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. More info can be found at the Biomed Israel website.
The FDA looked at the data, saw it promising, and asked for a small feasibility study in the U.S. This will hopefully lead to an FDA approval for its first indication, after which Alpha TAU plans on expanding to other types of cancer and geographic regions such as Europe and Japan. The rest of the patients had partial responses.
The early-stage venture financing firm Canaan Partners focuses on game-changing innovations in information, digital technologies, and the medicalsciences. Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences. Canaan Partners.
Last month, CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) was the first BCMA-targeted CAR-T cell therapy to be approved for second-line treatment of multiple myeloma by the US Food and Drug Administration (FDA). Most recently, Imran has served as MedicalScience Liaison (MSL) Head, Oncology U.S. Medical Affairs.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content